| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/10/2008 | WO2008042435A2 Conformation specific antibodies that bind trefoil factors and methods of treating cancers and proliferation disorders using same |
| 04/10/2008 | WO2008042261A2 Anti-anthrax antibody, formulations thereof, and methods of use |
| 04/10/2008 | WO2008042236A2 Compositions and methods for diagnosing and treating cancer |
| 04/10/2008 | WO2008041710A1 Precipitated/inactivated influenza vaccine and method for production thereof |
| 04/10/2008 | WO2008041703A1 Adjuvant for influenza vaccine and influenza vaccine |
| 04/10/2008 | WO2008041050A1 Malaria vaccine based on fragments and combinations of fragments of the cs protein of plasmodium vivax |
| 04/10/2008 | WO2008041012A1 Pharmaceutical composition comprising antibodies against a toxin |
| 04/10/2008 | WO2008040802A1 Use of mva as adjuvant in the stimulation of antigen-presenting cells |
| 04/10/2008 | WO2008040759A1 Method for down-regulation of cripto |
| 04/10/2008 | WO2008040757A1 Vaccines against chlamydial infection |
| 04/10/2008 | WO2008040691A1 Therapeutic vaccine comprising mycobacterial heat shock protein 70 |
| 04/10/2008 | WO2008040372A1 Novel antagonists of the toll-like receptor 4 |
| 04/10/2008 | WO2008040362A2 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 04/10/2008 | WO2008040155A1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 04/10/2008 | WO2008040098A1 Immunogenic polypeptides derived from the cleavage loop of precursor hemagglutinin of an influenza virus |
| 04/10/2008 | WO2008024518A3 Hcv fusion polypeptides |
| 04/10/2008 | WO2008015578A3 Antitumor compositions containing acetylcyclopropyl docetaxel and trastuzumab |
| 04/10/2008 | WO2008011094A3 Cytokine induction of selectin ligands on cells |
| 04/10/2008 | WO2008009650A3 Vaccines for malaria |
| 04/10/2008 | WO2008008455A3 Method of treating multiple myeloma |
| 04/10/2008 | WO2008004128A3 Use of bacterial polysaccharides for biofilm inhibition |
| 04/10/2008 | WO2008002933A9 Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof |
| 04/10/2008 | WO2007149802A3 Formulation for delivery of immune response modifiers |
| 04/10/2008 | WO2007140457A3 Methods of using anti-thymocyte globulin and related agents |
| 04/10/2008 | WO2007127372A3 Genetic adjuvants for viral vaccines |
| 04/10/2008 | WO2007126856A3 Covalently-linked complexes of hiv tat and env proteins |
| 04/10/2008 | WO2007120767A3 Agonist erythropoietin receptor antibodies |
| 04/10/2008 | WO2007116089A3 Proder p 1 expressed in a prokaryotic cell |
| 04/10/2008 | WO2007092457A3 Ligands for virus channel proteins |
| 04/10/2008 | WO2007089445A3 Ang2 and vegf inhibitor combinations |
| 04/10/2008 | WO2007087064A3 Pneumococcal serotypes |
| 04/10/2008 | WO2007084715A3 Tat-031 and methods of assessing and treating cancer |
| 04/10/2008 | WO2007075342A3 Vaccine adjuvant |
| 04/10/2008 | WO2007062795A3 Bacterial vaccine against bacterial infective agents, to be used in animals |
| 04/10/2008 | WO2006106424A3 Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines |
| 04/10/2008 | US20080085995 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/10/2008 | US20080085870 Isolated polynucleotides comprising a nucleic acid which operably encodes 50 contiguous amino acids, nucleic acids are fragments of a codon-optimized coding region; a carrier |
| 04/10/2008 | US20080085861 Gas1 polypeptides |
| 04/10/2008 | US20080085545 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/10/2008 | US20080085299 Peptides derived from colostrinin |
| 04/10/2008 | US20080085289 An immunogenic composition comprising Staphylococcal poly-N-acetylglucosamine (PNAG) and Type 8 capsular polysaccharide or oligosaccharide from Staph aureus; vaccines; e.g., mixture of a Staph extracellular component binding protein and a staph transporter protein, regulator of virulence or toxin |
| 04/10/2008 | US20080085288 Method of Immunization Against The 4 Dengue Serotypes |
| 04/10/2008 | US20080085286 Mixture comprising fungal allergen for use as tool in generating polypeptides for prevention of microorganismal infection |
| 04/10/2008 | US20080085285 Use of recombinant heat shock protein complexed to kidney cancer antigen |
| 04/10/2008 | US20080085284 Construction of a Comparative Database and Identification of Virulence Factors Comparison of Polymorphic Regions in Clinical Isolates of Infectious Organisms |
| 04/10/2008 | US20080085283 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
| 04/10/2008 | US20080085282 Methods of detecting and controlling mucoid pseudomonas biofilm production |
| 04/10/2008 | US20080085281 Using modulators of Dickkopf homolog 1 (DKK-1) activity as tool in treatment and prevention of osteolytic lesion; wnt signaling antagonist; antitumor agents |
| 04/10/2008 | US20080085280 Using monoclonal antibody specific to bacterial ectodomain as tool in prevention and treatment of pancreatic, kidney and inflammatory disorders |
| 04/10/2008 | US20080085279 Murine double mutant binding protein (MTBP) inhibitor for use as tool in treatment and prevention of cell proliferative disorders |
| 04/10/2008 | US20080085278 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
| 04/10/2008 | US20080085277 Novel antigen-binding polypeptides and their uses |
| 04/10/2008 | US20080085276 Method of treating eye injury with local administration of a VEGF inhibitor |
| 04/10/2008 | US20080085275 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/10/2008 | US20080085274 Using tumor necrosis factor modulators/inhibitors as tool in treatment and prevention of spinal cord injury |
| 04/10/2008 | US20080085273 Vehicle for the transport of a chosen molecule to a cell |
| 04/10/2008 | US20080085272 Encapsulating therapeutic agent in spider silk fibroin; contolling release of pharmaceutical agents |
| 04/10/2008 | US20080085269 Vaccine And Method For Treatment Of Neurodegenerative Diseases |
| 04/10/2008 | US20080085261 Vaccine Adjuvant |
| 04/10/2008 | US20080085241 highly selective; tumor-specific binding proteins; amino acid sequence; nucleic acid molecule; recombinant expression vector; host cell; cancer diagnosis; identify only those markers recognized by the human immune system as sufficiently foreign to trigger the production of antibodies; antigen is CD98hc |
| 04/10/2008 | CA2665356A1 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 04/10/2008 | CA2665037A1 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions |
| 04/10/2008 | CA2664738A1 Compositions and methods for diagnosing and treating cancer |
| 04/10/2008 | CA2664567A1 Tumor immunity |
| 04/10/2008 | CA2664236A1 Vaccines against chlamydial infection |
| 04/10/2008 | CA2664157A1 Norovirus vaccine formulations |
| 04/10/2008 | CA2653628A1 Neuroactive fragments of app |
| 04/09/2008 | EP1908839A2 Virulence genes, proteins, and their use |
| 04/09/2008 | EP1908837A2 Human receptor proteins, related reagents and methods |
| 04/09/2008 | EP1908834A2 Heteromultimeric ion channel receptor and uses thereof |
| 04/09/2008 | EP1908826A1 Prostate cancer related protein derived peptide which is a peptide vaccine candidate for prostate cancer patients with hla-a3 supertype alleles |
| 04/09/2008 | EP1908825A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 04/09/2008 | EP1908823A1 Component of bromelain |
| 04/09/2008 | EP1908821A1 Use of mva as adjuvant in the stimulation of antigen-presenting cells |
| 04/09/2008 | EP1908780A1 Novel chimeric proteins and methods for using the same |
| 04/09/2008 | EP1908772A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 04/09/2008 | EP1908482A1 Stabilizer for protein preparation comprising meglumine and use thereof |
| 04/09/2008 | EP1908479A2 Anti-p53 Antibodies |
| 04/09/2008 | EP1908476A1 Galectin-2 for the treatment of inflammatory diseases of the skin |
| 04/09/2008 | EP1907857A2 Biomarkers for breast cancer |
| 04/09/2008 | EP1907610A2 Secretion of antibodies without signal peptides from bacteria |
| 04/09/2008 | EP1907572A2 Prostate stem cell markers |
| 04/09/2008 | EP1907537A2 Paramyxoviridae virus preparations |
| 04/09/2008 | EP1907535A2 Cdna construct of salmonidae alphavirus |
| 04/09/2008 | EP1907426A2 Novel anti-igf-ir antibodies and uses thereof |
| 04/09/2008 | EP1907423A2 Catalytic immunoglobulins |
| 04/09/2008 | EP1907420A2 Plexin d1 as a target for tumor diagnosis and therapy |
| 04/09/2008 | EP1907414A2 Parechovirus, vaccines, medicaments and diagnostic kits |
| 04/09/2008 | EP1907002A2 Methods of treating autoimmune disease using humanized anti-cd16a antibodies |
| 04/09/2008 | EP1907001A2 Ilt3 binding molecules and uses therefor |
| 04/09/2008 | EP1907000A2 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1)pathway |
| 04/09/2008 | EP1906999A1 Frizzled 9 as tumour marker |
| 04/09/2008 | EP1906998A1 Peptide-based influenza vaccine formulation |
| 04/09/2008 | EP1906997A2 Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 04/09/2008 | EP1906996A2 Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method |
| 04/09/2008 | EP1906995A2 Adjuvation through cross- structure |
| 04/09/2008 | EP1906986A1 Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 04/09/2008 | EP1906963A2 Method of treating ischemia-reperfusion injury |
| 04/09/2008 | EP1906923A2 Systems and methods for delivery of a therapeutic agent |
| 04/09/2008 | EP1660118B1 Method for identification of regulatory tr1 lymphocytes by the presence and overexpression of specific molecules and application thereof |